Adma Biologics (ADMA) Capital Expenditures Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
-33.87% |
| Date | Value |
|---|
| Dec 31, 2025 |
-33.87% |
| Sep 30, 2025 |
61.98% |
| Jun 30, 2025 |
-14.97% |
| Mar 31, 2025 |
18.26% |
| Dec 31, 2024 |
-9.14% |
| Sep 30, 2024 |
-27.65% |
| Jun 30, 2024 |
-22.72% |
| Mar 31, 2024 |
-2.99% |
| Dec 31, 2023 |
-30.71% |
| Sep 30, 2023 |
-35.98% |
| Jun 30, 2023 |
-40.64% |
| Mar 31, 2023 |
-2.13% |
| Dec 31, 2022 |
32.97% |
| Sep 30, 2022 |
11.13% |
| Jun 30, 2022 |
135.52% |
| Mar 31, 2022 |
195.23% |
| Dec 31, 2021 |
64.95% |
| Sep 30, 2021 |
129.66% |
| Jun 30, 2021 |
108.03% |
| Mar 31, 2021 |
67.28% |
